nodes	percent_of_prediction	percent_of_DWPC	metapath
Fludrocortisone—NR3C1—Nuclear Receptors—NR1I3—liver cancer	0.0109	0.0157	CbGpPWpGaD
Fludrocortisone—NR3C1—FOXA2 and FOXA3 transcription factor networks—CPT1B—liver cancer	0.0102	0.0147	CbGpPWpGaD
Fludrocortisone—NR3C2—ACE Inhibitor Pathway—TGFB1—liver cancer	0.0101	0.0145	CbGpPWpGaD
Fludrocortisone—AR—Nuclear Receptors—HNF4A—liver cancer	0.00994	0.0143	CbGpPWpGaD
Fludrocortisone—Cardiomegaly—Epirubicin—liver cancer	0.00959	0.0336	CcSEcCtD
Fludrocortisone—AR—FOXA1 transcription factor network—SERPINA1—liver cancer	0.00909	0.0131	CbGpPWpGaD
Fludrocortisone—NR3C2—Nuclear Receptor transcription pathway—PPARA—liver cancer	0.0089	0.0128	CbGpPWpGaD
Fludrocortisone—Cardiomegaly—Doxorubicin—liver cancer	0.00887	0.0311	CcSEcCtD
Fludrocortisone—NR3C1—Nuclear Receptor transcription pathway—NR1H4—liver cancer	0.00875	0.0126	CbGpPWpGaD
Fludrocortisone—NR3C1—Nuclear Receptor transcription pathway—NR1I3—liver cancer	0.0086	0.0124	CbGpPWpGaD
Fludrocortisone—Neoplasm—Sorafenib—liver cancer	0.00856	0.03	CcSEcCtD
Fludrocortisone—NR3C2—Nuclear Receptor transcription pathway—ESR1—liver cancer	0.00806	0.0116	CbGpPWpGaD
Fludrocortisone—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALDOB—liver cancer	0.00789	0.0114	CbGpPWpGaD
Fludrocortisone—AR—Nuclear Receptor transcription pathway—HNF4A—liver cancer	0.00786	0.0113	CbGpPWpGaD
Fludrocortisone—AR—Coregulation of Androgen receptor activity—TCF4—liver cancer	0.00785	0.0113	CbGpPWpGaD
Fludrocortisone—Cardiac failure congestive—Sorafenib—liver cancer	0.00757	0.0266	CcSEcCtD
Fludrocortisone—NR3C1—Nuclear Receptors—HNF4A—liver cancer	0.00754	0.0109	CbGpPWpGaD
Fludrocortisone—NR3C2—Nuclear Receptor transcription pathway—PPARG—liver cancer	0.00735	0.0106	CbGpPWpGaD
Fludrocortisone—NR3C1—FOXA2 and FOXA3 transcription factor networks—HNF4A—liver cancer	0.00671	0.00966	CbGpPWpGaD
Fludrocortisone—Hypernatraemia—Epirubicin—liver cancer	0.00665	0.0233	CcSEcCtD
Fludrocortisone—Mood swings—Sorafenib—liver cancer	0.00651	0.0228	CcSEcCtD
Fludrocortisone—NR3C2—Preimplantation Embryo—CDH1—liver cancer	0.00633	0.00911	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—TCF4—liver cancer	0.00632	0.0091	CbGpPWpGaD
Fludrocortisone—Hypernatraemia—Doxorubicin—liver cancer	0.00615	0.0216	CcSEcCtD
Fludrocortisone—NR3C1—Nuclear Receptor transcription pathway—HNF4A—liver cancer	0.00596	0.00858	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—NR1I3—liver cancer	0.00588	0.00847	CbGpPWpGaD
Fludrocortisone—Skin hyperpigmentation—Epirubicin—liver cancer	0.00588	0.0206	CcSEcCtD
Fludrocortisone—Pancreatitis—Sorafenib—liver cancer	0.00582	0.0204	CcSEcCtD
Fludrocortisone—Optic neuritis—Epirubicin—liver cancer	0.00569	0.0199	CcSEcCtD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—ATF3—liver cancer	0.00562	0.00809	CbGpPWpGaD
Fludrocortisone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—BRAF—liver cancer	0.00555	0.008	CbGpPWpGaD
Fludrocortisone—Skin hyperpigmentation—Doxorubicin—liver cancer	0.00544	0.0191	CcSEcCtD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—HNF4A—liver cancer	0.00543	0.00782	CbGpPWpGaD
Fludrocortisone—Optic neuritis—Doxorubicin—liver cancer	0.00526	0.0184	CcSEcCtD
Fludrocortisone—AR—Nuclear Receptors—PPARA—liver cancer	0.00522	0.00752	CbGpPWpGaD
Fludrocortisone—NR3C1—Transcription factor regulation in adipogenesis—PPARG—liver cancer	0.00507	0.0073	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—SCD—liver cancer	0.00491	0.00707	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—ATF3—liver cancer	0.00479	0.0069	CbGpPWpGaD
Fludrocortisone—Haemoglobin—Sorafenib—liver cancer	0.00478	0.0167	CcSEcCtD
Fludrocortisone—Haemorrhage—Sorafenib—liver cancer	0.00475	0.0167	CcSEcCtD
Fludrocortisone—AR—Nuclear Receptors—ESR1—liver cancer	0.00473	0.00681	CbGpPWpGaD
Fludrocortisone—Dermatitis atopic—Epirubicin—liver cancer	0.00472	0.0166	CcSEcCtD
Fludrocortisone—Dermatitis atopic—Doxorubicin—liver cancer	0.00437	0.0153	CcSEcCtD
Fludrocortisone—AR—Nuclear Receptors—PPARG—liver cancer	0.00432	0.00622	CbGpPWpGaD
Fludrocortisone—Glycosuria—Epirubicin—liver cancer	0.00432	0.0151	CcSEcCtD
Fludrocortisone—NR3C2—Generic Transcription Pathway—NR1H4—liver cancer	0.00429	0.00618	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—ATF3—liver cancer	0.00426	0.00614	CbGpPWpGaD
Fludrocortisone—Petechiae—Epirubicin—liver cancer	0.00425	0.0149	CcSEcCtD
Fludrocortisone—NR3C2—Generic Transcription Pathway—NR1I3—liver cancer	0.00422	0.00608	CbGpPWpGaD
Fludrocortisone—AR—FOXA1 transcription factor network—ESR1—liver cancer	0.00421	0.00606	CbGpPWpGaD
Fludrocortisone—Erythema—Sorafenib—liver cancer	0.00414	0.0145	CcSEcCtD
Fludrocortisone—AR—Nongenotropic Androgen signaling—RAF1—liver cancer	0.00413	0.00595	CbGpPWpGaD
Fludrocortisone—AR—Nuclear Receptor transcription pathway—PPARA—liver cancer	0.00413	0.00594	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—HNF4A—liver cancer	0.00412	0.00593	CbGpPWpGaD
Fludrocortisone—AR—Notch-mediated HES/HEY network—KDR—liver cancer	0.0041	0.0059	CbGpPWpGaD
Fludrocortisone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—PPARA—liver cancer	0.00405	0.00583	CbGpPWpGaD
Fludrocortisone—Glycosuria—Doxorubicin—liver cancer	0.00399	0.014	CcSEcCtD
Fludrocortisone—Amenorrhoea—Epirubicin—liver cancer	0.00398	0.014	CcSEcCtD
Fludrocortisone—NR3C1—Nuclear Receptors—PPARA—liver cancer	0.00396	0.00571	CbGpPWpGaD
Fludrocortisone—Petechiae—Doxorubicin—liver cancer	0.00393	0.0138	CcSEcCtD
Fludrocortisone—AR—Nuclear Receptor transcription pathway—ESR1—liver cancer	0.00374	0.00539	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—AHR—liver cancer	0.0037	0.00533	CbGpPWpGaD
Fludrocortisone—AR—Regulation of Androgen receptor activity—MAPK14—liver cancer	0.0037	0.00532	CbGpPWpGaD
Fludrocortisone—Amenorrhoea—Doxorubicin—liver cancer	0.00368	0.0129	CcSEcCtD
Fludrocortisone—NR3C1—Signaling events mediated by HDAC Class II—ESR1—liver cancer	0.00359	0.00517	CbGpPWpGaD
Fludrocortisone—NR3C1—Nuclear Receptors—ESR1—liver cancer	0.00359	0.00517	CbGpPWpGaD
Fludrocortisone—Hypertension—Sorafenib—liver cancer	0.00357	0.0125	CcSEcCtD
Fludrocortisone—Myalgia—Sorafenib—liver cancer	0.00352	0.0123	CcSEcCtD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—FST—liver cancer	0.00351	0.00506	CbGpPWpGaD
Fludrocortisone—Fluoxymesterone—ESR1—liver cancer	0.0035	0.173	CrCbGaD
Fludrocortisone—AR—Nuclear Receptor transcription pathway—PPARG—liver cancer	0.00341	0.00491	CbGpPWpGaD
Fludrocortisone—NR3C1—Transcription factor regulation in adipogenesis—MAPK8—liver cancer	0.0034	0.0049	CbGpPWpGaD
Fludrocortisone—Clobetasol propionate—CYP1A1—liver cancer	0.00339	0.168	CrCbGaD
Fludrocortisone—Anaphylactic shock—Sorafenib—liver cancer	0.00338	0.0118	CcSEcCtD
Fludrocortisone—Infection—Sorafenib—liver cancer	0.00335	0.0118	CcSEcCtD
Fludrocortisone—Fluid retention—Epirubicin—liver cancer	0.00332	0.0116	CcSEcCtD
Fludrocortisone—NR3C1—Nuclear Receptors—PPARG—liver cancer	0.00328	0.00472	CbGpPWpGaD
Fludrocortisone—Oesophagitis—Epirubicin—liver cancer	0.0032	0.0112	CcSEcCtD
Fludrocortisone—Rash maculo-papular—Epirubicin—liver cancer	0.00318	0.0111	CcSEcCtD
Fludrocortisone—NR3C1—Adipogenesis—AHR—liver cancer	0.00316	0.00456	CbGpPWpGaD
Fludrocortisone—Ecchymosis—Epirubicin—liver cancer	0.00316	0.0111	CcSEcCtD
Fludrocortisone—Neoplasm—Epirubicin—liver cancer	0.00316	0.0111	CcSEcCtD
Fludrocortisone—NR3C1—FOXA2 and FOXA3 transcription factor networks—F2—liver cancer	0.00315	0.00454	CbGpPWpGaD
Fludrocortisone—NR3C1—Nuclear Receptor transcription pathway—PPARA—liver cancer	0.00313	0.00451	CbGpPWpGaD
Fludrocortisone—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00308	0.0108	CcSEcCtD
Fludrocortisone—Fluid retention—Doxorubicin—liver cancer	0.00307	0.0108	CcSEcCtD
Fludrocortisone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—liver cancer	0.00301	0.00434	CbGpPWpGaD
Fludrocortisone—Medroxyprogesterone Acetate—ESR1—liver cancer	0.00301	0.149	CrCbGaD
Fludrocortisone—Oesophagitis—Doxorubicin—liver cancer	0.00296	0.0104	CcSEcCtD
Fludrocortisone—NR3C1—Circadian Clock—PPARA—liver cancer	0.00295	0.00425	CbGpPWpGaD
Fludrocortisone—Rash maculo-papular—Doxorubicin—liver cancer	0.00294	0.0103	CcSEcCtD
Fludrocortisone—Thrombophlebitis—Epirubicin—liver cancer	0.00293	0.0103	CcSEcCtD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—TERT—liver cancer	0.00293	0.00421	CbGpPWpGaD
Fludrocortisone—Ecchymosis—Doxorubicin—liver cancer	0.00293	0.0103	CcSEcCtD
Fludrocortisone—Neoplasm—Doxorubicin—liver cancer	0.00293	0.0103	CcSEcCtD
Fludrocortisone—NR3C2—Generic Transcription Pathway—HNF4A—liver cancer	0.00293	0.00421	CbGpPWpGaD
Fludrocortisone—Diabetes mellitus—Epirubicin—liver cancer	0.00292	0.0102	CcSEcCtD
Fludrocortisone—AR—FOXA1 transcription factor network—CDKN1B—liver cancer	0.00286	0.00412	CbGpPWpGaD
Fludrocortisone—Vascular purpura—Epirubicin—liver cancer	0.00284	0.00995	CcSEcCtD
Fludrocortisone—NR3C1—Nuclear Receptor transcription pathway—ESR1—liver cancer	0.00284	0.00409	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of Androgen receptor activity—MAPK14—liver cancer	0.0028	0.00404	CbGpPWpGaD
Fludrocortisone—Cardiac failure congestive—Epirubicin—liver cancer	0.0028	0.00981	CcSEcCtD
Fludrocortisone—NR3C1—AP-1 transcription factor network—CSF2—liver cancer	0.00277	0.00399	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—HNF4A—liver cancer	0.00273	0.00393	CbGpPWpGaD
Fludrocortisone—AR—FOXA1 transcription factor network—JUN—liver cancer	0.00272	0.00392	CbGpPWpGaD
Fludrocortisone—AR—Notch-mediated HES/HEY network—CDKN1B—liver cancer	0.00271	0.00391	CbGpPWpGaD
Fludrocortisone—Thrombophlebitis—Doxorubicin—liver cancer	0.00271	0.00951	CcSEcCtD
Fludrocortisone—Diabetes mellitus—Doxorubicin—liver cancer	0.0027	0.00947	CcSEcCtD
Fludrocortisone—NR3C1—Transcription factor regulation in adipogenesis—TNF—liver cancer	0.00269	0.00388	CbGpPWpGaD
Fludrocortisone—Urticaria—Sorafenib—liver cancer	0.00268	0.0094	CcSEcCtD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—HPGDS—liver cancer	0.00268	0.00386	CbGpPWpGaD
Fludrocortisone—Purpura—Epirubicin—liver cancer	0.00263	0.00923	CcSEcCtD
Fludrocortisone—Vascular purpura—Doxorubicin—liver cancer	0.00263	0.0092	CcSEcCtD
Fludrocortisone—Anaphylactoid reaction—Epirubicin—liver cancer	0.00262	0.00919	CcSEcCtD
Fludrocortisone—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—liver cancer	0.00262	0.00377	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—EXOSC2—liver cancer	0.0026	0.00374	CbGpPWpGaD
Fludrocortisone—Cardiac failure congestive—Doxorubicin—liver cancer	0.00259	0.00908	CcSEcCtD
Fludrocortisone—NR3C1—Nuclear Receptor transcription pathway—PPARG—liver cancer	0.00259	0.00373	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—ESR1—liver cancer	0.00258	0.00372	CbGpPWpGaD
Fludrocortisone—Affect lability—Epirubicin—liver cancer	0.0025	0.00876	CcSEcCtD
Fludrocortisone—AR—Coregulation of Androgen receptor activity—CDKN2A—liver cancer	0.00249	0.00358	CbGpPWpGaD
Fludrocortisone—Hypersensitivity—Sorafenib—liver cancer	0.00249	0.00872	CcSEcCtD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—APC—liver cancer	0.00247	0.00355	CbGpPWpGaD
Fludrocortisone—AR—Nongenotropic Androgen signaling—PIK3CA—liver cancer	0.00246	0.00354	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—CSF2—liver cancer	0.00244	0.00352	CbGpPWpGaD
Fludrocortisone—Purpura—Doxorubicin—liver cancer	0.00244	0.00854	CcSEcCtD
Fludrocortisone—Anaphylactoid reaction—Doxorubicin—liver cancer	0.00243	0.00851	CcSEcCtD
Fludrocortisone—Asthenia—Sorafenib—liver cancer	0.00242	0.00849	CcSEcCtD
Fludrocortisone—Mood swings—Epirubicin—liver cancer	0.0024	0.00843	CcSEcCtD
Fludrocortisone—AR—Regulation of Androgen receptor activity—JUN—liver cancer	0.00235	0.00338	CbGpPWpGaD
Fludrocortisone—Affect lability—Doxorubicin—liver cancer	0.00231	0.0081	CcSEcCtD
Fludrocortisone—AR—Nongenotropic Androgen signaling—HRAS—liver cancer	0.00228	0.00328	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDH1—liver cancer	0.00227	0.00327	CbGpPWpGaD
Fludrocortisone—Muscular weakness—Epirubicin—liver cancer	0.00224	0.00785	CcSEcCtD
Fludrocortisone—AR—Notch-mediated HES/HEY network—STAT3—liver cancer	0.00223	0.00322	CbGpPWpGaD
Fludrocortisone—Mood swings—Doxorubicin—liver cancer	0.00223	0.0078	CcSEcCtD
Fludrocortisone—AR—Regulation of Androgen receptor activity—MAPK8—liver cancer	0.00222	0.0032	CbGpPWpGaD
Fludrocortisone—Abdominal distension—Epirubicin—liver cancer	0.00221	0.00774	CcSEcCtD
Fludrocortisone—NR3C1—AP-1 transcription factor network—ESR1—liver cancer	0.0022	0.00317	CbGpPWpGaD
Fludrocortisone—NR3C1—Circadian Clock—SERPINE1—liver cancer	0.0022	0.00316	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—liver cancer	0.00219	0.00315	CbGpPWpGaD
Fludrocortisone—NR3C1—Transcription factor regulation in adipogenesis—IL6—liver cancer	0.00217	0.00313	CbGpPWpGaD
Fludrocortisone—Pancreatitis—Epirubicin—liver cancer	0.00215	0.00754	CcSEcCtD
Fludrocortisone—NR3C1—Endoderm Differentiation—APC—liver cancer	0.00213	0.00307	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—ABL1—liver cancer	0.00213	0.00306	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—SERPINE1—liver cancer	0.00212	0.00306	CbGpPWpGaD
Fludrocortisone—Headache—Sorafenib—liver cancer	0.00212	0.00741	CcSEcCtD
Fludrocortisone—AR—Coregulation of Androgen receptor activity—CCND1—liver cancer	0.0021	0.00303	CbGpPWpGaD
Fludrocortisone—AR—Coregulation of Androgen receptor activity—CTNNB1—liver cancer	0.00208	0.003	CbGpPWpGaD
Fludrocortisone—Muscular weakness—Doxorubicin—liver cancer	0.00207	0.00726	CcSEcCtD
Fludrocortisone—NR3C2—Gene Expression—NR1H4—liver cancer	0.00207	0.00298	CbGpPWpGaD
Fludrocortisone—Abdominal distension—Doxorubicin—liver cancer	0.00204	0.00716	CcSEcCtD
Fludrocortisone—NR3C2—Gene Expression—NR1I3—liver cancer	0.00203	0.00293	CbGpPWpGaD
Fludrocortisone—AR—Nongenotropic Androgen signaling—AKT1—liver cancer	0.00201	0.00289	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—liver cancer	0.002	0.00288	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—NR1H4—liver cancer	0.00199	0.00287	CbGpPWpGaD
Fludrocortisone—Pancreatitis—Doxorubicin—liver cancer	0.00199	0.00698	CcSEcCtD
Fludrocortisone—Hyperglycaemia—Epirubicin—liver cancer	0.00198	0.00694	CcSEcCtD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—MAPK14—liver cancer	0.00198	0.00285	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—liver cancer	0.00196	0.00282	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—NR1I3—liver cancer	0.00196	0.00282	CbGpPWpGaD
Fludrocortisone—Hyperglycaemia—Doxorubicin—liver cancer	0.00183	0.00642	CcSEcCtD
Fludrocortisone—NR3C1—Regulation of Androgen receptor activity—JUN—liver cancer	0.00178	0.00256	CbGpPWpGaD
Fludrocortisone—Haemoglobin—Epirubicin—liver cancer	0.00177	0.00619	CcSEcCtD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—ABL1—liver cancer	0.00176	0.00254	CbGpPWpGaD
Fludrocortisone—Haemorrhage—Epirubicin—liver cancer	0.00176	0.00616	CcSEcCtD
Fludrocortisone—Progesterone—ESR1—liver cancer	0.00174	0.0858	CrCbGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—liver cancer	0.00169	0.00244	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—CDKN2A—liver cancer	0.00169	0.00243	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—JUN—liver cancer	0.00169	0.00243	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of Androgen receptor activity—MAPK8—liver cancer	0.00168	0.00243	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—liver cancer	0.00168	0.00241	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—JUN—liver cancer	0.00167	0.00241	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—liver cancer	0.00164	0.00236	CbGpPWpGaD
Fludrocortisone—Haemoglobin—Doxorubicin—liver cancer	0.00163	0.00573	CcSEcCtD
Fludrocortisone—Haemorrhage—Doxorubicin—liver cancer	0.00162	0.0057	CcSEcCtD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—CDKN1A—liver cancer	0.00162	0.00233	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—liver cancer	0.00161	0.00232	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—ESR1—liver cancer	0.00157	0.00226	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—CCND1—liver cancer	0.00155	0.00224	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—JUN—liver cancer	0.00155	0.00223	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—CTNNB1—liver cancer	0.00154	0.00222	CbGpPWpGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—PPARA—liver cancer	0.00154	0.00221	CbGpPWpGaD
Fludrocortisone—Erythema—Epirubicin—liver cancer	0.00153	0.00536	CcSEcCtD
Fludrocortisone—NR3C1—Generic Transcription Pathway—NR1H4—liver cancer	0.00151	0.00218	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—PCNA—liver cancer	0.00151	0.00218	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—CDKN1A—liver cancer	0.0015	0.00216	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—CDKN1B—liver cancer	0.0015	0.00216	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—NR1I3—liver cancer	0.00149	0.00214	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—PPARA—liver cancer	0.00148	0.00213	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—IL2—liver cancer	0.00147	0.00211	CbGpPWpGaD
Fludrocortisone—NR3C1—Endoderm Differentiation—CTNNB1—liver cancer	0.00145	0.00208	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—CCND1—liver cancer	0.00143	0.00206	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—JUN—liver cancer	0.00143	0.00205	CbGpPWpGaD
Fludrocortisone—Erythema—Doxorubicin—liver cancer	0.00141	0.00496	CcSEcCtD
Fludrocortisone—NR3C1—AP-1 transcription factor network—CTNNB1—liver cancer	0.00141	0.00204	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—HNF4A—liver cancer	0.00141	0.00203	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—BRAF—liver cancer	0.00139	0.00201	CbGpPWpGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—ESR1—liver cancer	0.00139	0.002	CbGpPWpGaD
Fludrocortisone—Progesterone—CYP1A1—liver cancer	0.00139	0.0686	CrCbGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—MMP9—liver cancer	0.00139	0.002	CbGpPWpGaD
Fludrocortisone—Vertigo—Epirubicin—liver cancer	0.00137	0.00481	CcSEcCtD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—CDH1—liver cancer	0.00137	0.00197	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—HNF4A—liver cancer	0.00136	0.00195	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—liver cancer	0.00136	0.00195	CbGpPWpGaD
Fludrocortisone—Prednisone—ALB—liver cancer	0.00135	0.0665	CrCbGaD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—MYC—liver cancer	0.00134	0.00193	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—STAT3—liver cancer	0.00134	0.00193	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—MAPK14—liver cancer	0.00133	0.00191	CbGpPWpGaD
Fludrocortisone—Convulsion—Epirubicin—liver cancer	0.00132	0.00464	CcSEcCtD
Fludrocortisone—Hypertension—Epirubicin—liver cancer	0.00132	0.00463	CcSEcCtD
Fludrocortisone—Testosterone—CYP1A1—liver cancer	0.00131	0.0649	CrCbGaD
Fludrocortisone—Myalgia—Epirubicin—liver cancer	0.0013	0.00456	CcSEcCtD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—ESR1—liver cancer	0.0013	0.00187	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—IL2—liver cancer	0.00129	0.00186	CbGpPWpGaD
Fludrocortisone—Dexamethasone—CYP2E1—liver cancer	0.00129	0.0636	CrCbGaD
Fludrocortisone—Vertigo—Doxorubicin—liver cancer	0.00127	0.00445	CcSEcCtD
Fludrocortisone—NR3C2—Generic Transcription Pathway—PPARG—liver cancer	0.00127	0.00183	CbGpPWpGaD
Fludrocortisone—Dexamethasone—CYP1A1—liver cancer	0.00127	0.0628	CrCbGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—liver cancer	0.00127	0.00183	CbGpPWpGaD
Fludrocortisone—Methyltestosterone—ALB—liver cancer	0.00126	0.0623	CrCbGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—JUN—liver cancer	0.00126	0.00181	CbGpPWpGaD
Fludrocortisone—Oedema—Epirubicin—liver cancer	0.00125	0.00437	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Epirubicin—liver cancer	0.00125	0.00437	CcSEcCtD
Fludrocortisone—Infection—Epirubicin—liver cancer	0.00124	0.00435	CcSEcCtD
Fludrocortisone—NR3C2—Gene Expression—PSMA4—liver cancer	0.00123	0.00177	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—PSMD10—liver cancer	0.00123	0.00177	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—liver cancer	0.00123	0.00177	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—APC—liver cancer	0.00123	0.00177	CbGpPWpGaD
Fludrocortisone—Convulsion—Doxorubicin—liver cancer	0.00123	0.0043	CcSEcCtD
Fludrocortisone—NR3C1—Adipogenesis—PPARG—liver cancer	0.00122	0.00176	CbGpPWpGaD
Fludrocortisone—Hypertension—Doxorubicin—liver cancer	0.00122	0.00428	CcSEcCtD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—liver cancer	0.00122	0.00175	CbGpPWpGaD
Fludrocortisone—Hyperhidrosis—Epirubicin—liver cancer	0.00121	0.00423	CcSEcCtD
Fludrocortisone—AR—Gene Expression—EXOSC2—liver cancer	0.0012	0.00173	CbGpPWpGaD
Fludrocortisone—Myalgia—Doxorubicin—liver cancer	0.0012	0.00422	CcSEcCtD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—MAPK8—liver cancer	0.00119	0.00171	CbGpPWpGaD
Fludrocortisone—NR3C1—Endoderm Differentiation—TGFB1—liver cancer	0.00117	0.00168	CbGpPWpGaD
Fludrocortisone—AR—Coregulation of Androgen receptor activity—AKT1—liver cancer	0.00117	0.00168	CbGpPWpGaD
Fludrocortisone—Oedema—Doxorubicin—liver cancer	0.00115	0.00405	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Doxorubicin—liver cancer	0.00115	0.00405	CcSEcCtD
Fludrocortisone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—liver cancer	0.00115	0.00166	CbGpPWpGaD
Fludrocortisone—Infection—Doxorubicin—liver cancer	0.00115	0.00402	CcSEcCtD
Fludrocortisone—NR3C1—AP-1 transcription factor network—MYC—liver cancer	0.00115	0.00165	CbGpPWpGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—SERPINE1—liver cancer	0.00114	0.00165	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—TGFB1—liver cancer	0.00114	0.00165	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—MTOR—liver cancer	0.00114	0.00164	CbGpPWpGaD
Fludrocortisone—Musculoskeletal discomfort—Epirubicin—liver cancer	0.00114	0.00398	CcSEcCtD
Fludrocortisone—Insomnia—Epirubicin—liver cancer	0.00113	0.00396	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Doxorubicin—liver cancer	0.00112	0.00391	CcSEcCtD
Fludrocortisone—NR3C1—Adipogenesis—SERPINE1—liver cancer	0.0011	0.00159	CbGpPWpGaD
Fludrocortisone—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.00105	0.00369	CcSEcCtD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—CASP3—liver cancer	0.00105	0.00151	CbGpPWpGaD
Fludrocortisone—Insomnia—Doxorubicin—liver cancer	0.00104	0.00366	CcSEcCtD
Fludrocortisone—NR3C1—Generic Transcription Pathway—HNF4A—liver cancer	0.00103	0.00148	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—liver cancer	0.00102	0.00147	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—CASP3—liver cancer	0.00102	0.00147	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—CCND1—liver cancer	0.00102	0.00147	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—JUN—liver cancer	0.00102	0.00146	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—CTNNB1—liver cancer	0.00101	0.00145	CbGpPWpGaD
Fludrocortisone—Urticaria—Epirubicin—liver cancer	0.000991	0.00347	CcSEcCtD
Fludrocortisone—AR—SIDS Susceptibility Pathways—JUN—liver cancer	0.000989	0.00142	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—CTNNB1—liver cancer	0.000982	0.00141	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—RAF1—liver cancer	0.000965	0.00139	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—NR1H4—liver cancer	0.000959	0.00138	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—NR1I3—liver cancer	0.000943	0.00136	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—TP53—liver cancer	0.000941	0.00135	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—liver cancer	0.000932	0.00134	CbGpPWpGaD
Fludrocortisone—Hypersensitivity—Epirubicin—liver cancer	0.000919	0.00322	CcSEcCtD
Fludrocortisone—Urticaria—Doxorubicin—liver cancer	0.000917	0.00321	CcSEcCtD
Fludrocortisone—NR3C1—Gene Expression—EXOSC2—liver cancer	0.000914	0.00132	CbGpPWpGaD
Fludrocortisone—Asthenia—Epirubicin—liver cancer	0.000895	0.00314	CcSEcCtD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—VEGFA—liver cancer	0.000887	0.00128	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—CDKN1B—liver cancer	0.000884	0.00127	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—CASP3—liver cancer	0.000866	0.00125	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—VEGFA—liver cancer	0.000864	0.00124	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—AKT1—liver cancer	0.000864	0.00124	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—CTNNB1—liver cancer	0.000862	0.00124	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—IL6—liver cancer	0.000861	0.00124	CbGpPWpGaD
Fludrocortisone—Hypersensitivity—Doxorubicin—liver cancer	0.000851	0.00298	CcSEcCtD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—CCND1—liver cancer	0.000843	0.00121	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—CDKN1A—liver cancer	0.000842	0.00121	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—JUN—liver cancer	0.000842	0.00121	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—liver cancer	0.000835	0.0012	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—H2AFX—liver cancer	0.000832	0.0012	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—TP53—liver cancer	0.000829	0.00119	CbGpPWpGaD
Fludrocortisone—Asthenia—Doxorubicin—liver cancer	0.000828	0.0029	CcSEcCtD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—MYC—liver cancer	0.000816	0.00118	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—CDKN1A—liver cancer	0.000816	0.00117	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—MAPK8—liver cancer	0.000796	0.00115	CbGpPWpGaD
Fludrocortisone—Headache—Epirubicin—liver cancer	0.000782	0.00274	CcSEcCtD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—CASP3—liver cancer	0.000773	0.00111	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—IL6—liver cancer	0.000759	0.00109	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—KRAS—liver cancer	0.000754	0.00109	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—STAT3—liver cancer	0.000751	0.00108	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—JUN—liver cancer	0.000751	0.00108	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—CTNNB1—liver cancer	0.000745	0.00107	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—TNF—liver cancer	0.000741	0.00107	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—PPARA—liver cancer	0.00074	0.00107	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—liver cancer	0.000735	0.00106	CbGpPWpGaD
Fludrocortisone—Testosterone—ALB—liver cancer	0.00073	0.0361	CrCbGaD
Fludrocortisone—NR3C1—Gene Expression—NR1H4—liver cancer	0.000728	0.00105	CbGpPWpGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—MYC—liver cancer	0.000724	0.00104	CbGpPWpGaD
Fludrocortisone—Headache—Doxorubicin—liver cancer	0.000723	0.00254	CcSEcCtD
Fludrocortisone—NR3C1—Gene Expression—NR1I3—liver cancer	0.000715	0.00103	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—PPARA—liver cancer	0.000713	0.00103	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—liver cancer	0.000707	0.00102	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—liver cancer	0.0007	0.00101	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—TGFB1—liver cancer	0.000696	0.001	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—MAPK14—liver cancer	0.000683	0.000984	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	0.000676	0.000974	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	0.000675	0.000972	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—TP53—liver cancer	0.00067	0.000965	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—ESR1—liver cancer	0.00067	0.000965	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—VEGFA—liver cancer	0.000656	0.000944	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—HNF4A—liver cancer	0.000654	0.000941	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—TNF—liver cancer	0.00065	0.000936	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—ESR1—liver cancer	0.000646	0.00093	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	0.00063	0.000907	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	0.000625	0.0009	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—PPARG—liver cancer	0.000612	0.000881	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—IL6—liver cancer	0.000598	0.000861	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—PPARG—liver cancer	0.000589	0.000849	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	0.000574	0.000827	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—PSMA4—liver cancer	0.000571	0.000823	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—PSMD10—liver cancer	0.000571	0.000823	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—AKT1—liver cancer	0.000566	0.000815	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—TNF—liver cancer	0.000562	0.000809	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	0.000556	0.0008	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—SERPINE1—liver cancer	0.000551	0.000793	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—PPARA—liver cancer	0.000541	0.000779	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—SERPINE1—liver cancer	0.000531	0.000765	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—IL6—liver cancer	0.000525	0.000756	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—HNF4A—liver cancer	0.000496	0.000714	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—ESR1—liver cancer	0.00049	0.000706	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	0.000469	0.000675	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—IL6—liver cancer	0.000454	0.000653	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—PPARG—liver cancer	0.000447	0.000644	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—PSMD10—liver cancer	0.000433	0.000624	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—PSMA4—liver cancer	0.000433	0.000624	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—SERPINE1—liver cancer	0.000403	0.00058	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—H2AFX—liver cancer	0.000386	0.000556	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—MYC—liver cancer	0.000349	0.000502	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—PPARA—liver cancer	0.000343	0.000494	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—MYC—liver cancer	0.000336	0.000484	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—MAPK14—liver cancer	0.000317	0.000457	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—ESR1—liver cancer	0.000311	0.000448	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—H2AFX—liver cancer	0.000293	0.000422	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—PPARG—liver cancer	0.000284	0.000409	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—PPARA—liver cancer	0.00026	0.000375	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—SERPINE1—liver cancer	0.000256	0.000368	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—MYC—liver cancer	0.000255	0.000367	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—AKT1—liver cancer	0.000242	0.000348	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—MAPK14—liver cancer	0.000241	0.000346	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—ESR1—liver cancer	0.000236	0.00034	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—PPARG—liver cancer	0.000215	0.00031	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—SERPINE1—liver cancer	0.000194	0.000279	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—MYC—liver cancer	0.000162	0.000233	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—MYC—liver cancer	0.000123	0.000177	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—AKT1—liver cancer	0.000112	0.000162	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—AKT1—liver cancer	8.51e-05	0.000123	CbGpPWpGaD
